Modelling prognostic factors in advanced pancreatic cancer.
Pancreatic cancer is the fifth most common cause of cancer death. Identification of defined patient groups based on a prognostic index may improve the prediction of survival and selection of therapy. Many prognostic factors have been identified often based on retrospective, underpowered studies with...
المؤلفون الرئيسيون: | Stocken, D, Hassan, A, Altman, D, Billingham, L, Bramhall, SR, Johnson, P, Freemantle, N |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2008
|
مواد مشابهة
-
Choice of transformation for modelling non-linear continuous biomarkers
حسب: Stocken Deborah D, وآخرون
منشور في: (2011-12-01) -
A phase II irinotecan-cisplatin combination in advanced pancreatic cancer.
حسب: Markham, C, وآخرون
منشور في: (2003) -
Prognostic models: a methodological framework and review of models for breast cancer.
حسب: Altman, D
منشور في: (2009) -
Advancing Prognostication in Pancreatic Cancer: A Comprehensive Cohort Analysis
حسب: Shikhar Tripathi, وآخرون
منشور في: (2024-09-01) -
Locally Advanced and Metastatic Pancreatic Cancer: Survival analysis and prognostic factors in a case series
حسب: Paloma Porto Amorim, وآخرون
منشور في: (2020-01-01)